Enliven Therapeutics, Inc. (ELVN): SC 13D/A filed Jul 29, 2024

Form type

SC 13D/A

Filing date

Jul 29, 2024

Accession number

0001104659-24-083627

Filer

Enliven Therapeutics, Inc. (CIK 1672619)